BioSpace News Archive

sphingotec Launches IVD Test for Kidney Function Biomarker penKid(R) on Nexus IB10 POCT Platform

sphingotec launches a CE-marked point-of-care IVD assay for Proenkephalin (penKid(R)), the company’s proprietary biomarker for real-time assessment of kidney function in critical care settings

January 15, 2020
·
7 min read
Business

MorphoSys and Incyte Sign Global Collaboration and License Agreement, including U.S. Co-Commercialization and Ex-U.S. Commercialization Rights, for Tafasitamab

MorphoSys AG announces that it has entered into a global collaboration and licensing agreement with Incyte Corporation to further develop and commercialize MorphoSys’ proprietary anti-CD19 antibody tafasitamab.

January 15, 2020
·
7 min read
apceth Starts Commercial Manufacturing of Zynteglo™ ▼, bluebird bio’s Gene Therapy for Transfusion-Dependent β-Thalassemia

apceth Biopharma GmbH, a subsidiary of Hitachi Chemical Co., Ltd. and a leading company for the manufacturing of cell and gene therapeutics, starts the commercial manufacturing of Zynteglo™ ▼, a product of bluebird bio, Inc.

January 15, 2020
·
3 min read
Drug Development

Critics Underwhelmed by Patrick Soon-Shiong’s ‘Cancer Moonshot’ Progress So Far

In 2016, Soon-Shiong announced the Cancer Moonshot and set a 2020 deadline, claiming he would transform the war on cancer.

January 15, 2020
·
3 min read
·
Mark Terry
Eli Lilly Unveils Another Round of Lower-Cost Insulin Products

The Indianapolis-based company announced lower-priced versions of Humalog Mix75/25 KwikPen (insulin lispro protamine and insulin lispro injectable suspension 100 units/mL) and Humalog Junior KwikPen (insulin lispro injection 100 units/mL).

January 15, 2020
·
3 min read
·
Alex Keown
The Digital Revolution: Digital Therapeutics, Drug Discovery and Beyond

It’s entirely possible that what is now being seen as a digital transformation in so many areas will in time merely become a standard set of tools used in all areas of the life sciences, from drug discovery and development, regulation and actual therapeutic devices.

January 15, 2020
·
8 min read
·
Mark Terry
Pharm Country

JPM Day 3: High Prices in San Francisco Are a Problem, Galapagos Strikes Fibrosis Deal

While the conditions surrounding the City by the Bay are in a negative light, there is still a significant amount of positive news coming out of the conference.

January 15, 2020
·
5 min read
·
Alex Keown
Drug Development

BioSpace Global Roundup, Jan. 16

Companies from across the globe provide updates to their business and pipeline.

January 15, 2020
·
7 min read
·
Alex Keown
Deals

Medtech innovator Xyall wins €5M Series A financing for its unique high-tech molecular pathology laboratory solution

Xyall BV has been identified as a next-generation global innovator in molecular pathology, winning Series A seed investment of €5 million from investment partners Sioux Technologies, BOM Brabant Ventures, the Netherlands Enterprise Agency and other private investors.

January 15, 2020
·
4 min read
Deals

The Defense Health Program Department of Defense Peer Reviewed Medical Research Program Anticipated Funding Opportunities for Fiscal Year 2020 (FY20)

The FY20 Defense Appropriations Act provides funding to the Department of Defense Peer Reviewed Medical Research Program to support medical research projects of clear scientific merit and direct relevance to military health.

January 15, 2020
·
2 min read